Pharmacist Intervention Impact on Alzheimer's Disease Patients in Brazil

A Brazilian secondary care center conducted a prospective, non-randomized study assessing pharmacist-led medication therapy management. The study included 66 patients with Alzheimer's disease, with 55 completing a six-month follow-up. Marcela Forgerini authored the research, which measured health outcomes like cognitive tests and blood pressure.

Use Cases

• Analyze the effectiveness of pharmacist-led interventions based on the resolution rate of drug-related problems.
• Study medication adherence patterns in Alzheimer's disease therapy based on reported non-adherence rates.
• Evaluate changes in clinical parameters like blood pressure and glucose levels based on the measured health outcomes.
• Associate the resolution of prodromal symptoms with patient withdrawal from the protocol.

Strengths

• Includes 66 patient records with a defined six-month follow-up period.
• Reports specific counts: 166 detected drug-related problems and 116 solved.
• Provides concrete clinical outcome measurements for blood pressure, glucose, cholesterol, and triglycerides.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to a single-center study in Brazil.

Provenance

Source

Marcela Forgerini

Collection Method

An interventional, prospective, non-randomized study conducted in a single secondary care center.

Time Range

Study duration of six months.

Geography

Brazil